HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by GAMMA Investing LLC

GAMMA Investing LLC increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 25.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,571 shares of the company’s stock after acquiring an additional 323 shares during the period. GAMMA Investing LLC’s holdings in HealthEquity were worth $139,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of HQY. Proficio Capital Partners LLC acquired a new position in HealthEquity during the fourth quarter worth about $39,000. Smartleaf Asset Management LLC grew its holdings in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares during the period. Jones Financial Companies Lllp grew its holdings in HealthEquity by 1,112.3% during the fourth quarter. Jones Financial Companies Lllp now owns 1,285 shares of the company’s stock worth $123,000 after acquiring an additional 1,179 shares during the period. State of Michigan Retirement System grew its holdings in HealthEquity by 0.5% during the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock worth $1,988,000 after acquiring an additional 100 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in HealthEquity by 2.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock worth $104,280,000 after acquiring an additional 25,004 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other HealthEquity news, Director Jon Kessler sold 134,183 shares of HealthEquity stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.08, for a total value of $15,039,230.64. Following the completion of the sale, the director owned 253,510 shares in the company, valued at $28,413,400.80. The trade was a 34.61% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director owned 84,969 shares of the company’s stock, valued at $6,597,842.85. This trade represents a 6.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 295,700 shares of company stock valued at $32,968,990 over the last ninety days. 1.50% of the stock is currently owned by company insiders.

HealthEquity Stock Down 1.7%

HealthEquity stock opened at $99.55 on Friday. The stock has a market capitalization of $8.61 billion, a PE ratio of 72.66, a price-to-earnings-growth ratio of 1.57 and a beta of 0.49. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $116.65. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The company has a 50 day moving average of $99.74 and a 200-day moving average of $98.29.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The business had revenue of $330.80 million during the quarter, compared to analysts’ expectations of $322.25 million. During the same quarter in the prior year, the company posted $0.80 earnings per share. On average, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on HQY shares. Deutsche Bank Aktiengesellschaft lifted their target price on HealthEquity from $98.00 to $115.00 and gave the stock a “buy” rating in a report on Thursday, June 5th. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research note on Friday, June 6th. Barrington Research upped their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, June 5th. Royal Bank Of Canada raised their target price on shares of HealthEquity from $112.00 to $117.00 and gave the stock an “outperform” rating in a report on Wednesday, June 4th. Finally, The Goldman Sachs Group lifted their target price on shares of HealthEquity from $94.00 to $104.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 4th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $118.09.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.